Elanco
Health and Wellness
Elanco’s Credelio™ (Lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) Against New World Screwworm (NWS) in Dogs
November 1, 2025
Health and Wellness
Elanco Innovation Builds Momentum, Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets) Reaches Blockbuster Status
September 10, 2025
Health and Wellness
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief
June 10, 2025
Health and Wellness
Elanco Enters Agreement With Medgene To Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle
February 27, 2025
Health and Wellness
Meet the Faces of Zen: Elanco’s Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal
February 1, 2025
Employee Engagement
Compassion, Pets, People, Complexity: Dr. Emily Swiniarski & Dr. Amanda Schnitker
September 19, 2024
Sustainability
Shared Table with Jeff Simmons | Trust, Cows, Milk, Climate: Dr. Frank Mitloehner
August 20, 2024
Environmental Resources
Elanco Announces FDA Has Completed Review of Bovaer®, First-in-Class Methane-Reducing Feed Ingredient, for U.S. Dairy Industry
May 30, 2024